Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
10:30am, Sunday, 22'nd Jan 2023 The Motley Fool
Two newer immunology drugs look like big tickets to growth.
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
05:30am, Sunday, 22'nd Jan 2023
Two newer immunology drugs look like big tickets to growth.
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
09:10pm, Saturday, 21'st Jan 2023 MarketWatch
Imbruvica seemed invincible in the marketplace. But a new book, “For Blood and Money,” shows how the drug’s creators left a trap door that led to its undoing.
Final Trades: Abbvie, Goldman Sachs, Charles River & more
03:56pm, Friday, 20'th Jan 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Dividend Kings of 2023
03:00pm, Friday, 20'th Jan 2023 The Motley Fool
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Better 2023 Dividend Stock: AbbVie Or Johnson & Johnson?
02:14pm, Friday, 20'th Jan 2023
My main thesis is to explain why AbbVie Inc. remains my top 2023 dividend stock in the healthcare space despite its near-record stock prices. The thesis is best illustrated by comparison and contrast
7 Stocks Every Smart Investor Should Own in 2023
11:55am, Friday, 20'th Jan 2023
At the rate things are going, a recession is likely. All thanks to the Federal Reserve, which once tried — laughably — to convince us inflation was transitory.
3 Unstoppable Stocks to Keep Buying in 2023
10:30am, Thursday, 19'th Jan 2023 The Motley Fool
These companies have what it takes to drive long-term share performance.
Nicholas Ward's Dividend Growth Portfolio: December/Full Year 2022 Review
04:46pm, Wednesday, 18'th Jan 2023
My passive income was up by 46.50% on a year-over-year basis during December. For the full-year in 2022, my passive income rose by 23.73%.
7 Biotech Stocks That Will Make You Rich in 10 Years
03:44pm, Wednesday, 18'th Jan 2023
If you have the patience to go through wild undulations, then you may be a candidate for biotech stocks that will make you rich in 10 years. Even among the most established biotechnology firms, they'r
2 Cheap Growth Stocks That Can Set You Up for Life
02:53pm, Wednesday, 18'th Jan 2023 The Motley Fool
Over the past 10 years, these stocks have each risen by more than 340%.
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
My Dividend Growth Portfolio - Q4 2022 Summary
01:23am, Wednesday, 18'th Jan 2023
In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its
AbbVie : To Buy Or Not To Buy
01:05am, Wednesday, 18'th Jan 2023 Seeking Alpha
AbbVie is a quality BBB+ S&P credit rated healthcare stock with a 3.9% yield. Click here to read more about ABBV stock and my recommendation.
AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know
10:45pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
In the latest trading session, AbbVie (ABBV) closed at $152.83, marking a -0.5% move from the previous day.
